Last updated: July 29, 2025
Introduction
Patent JP2018135382 was filed in Japan and pertains to a pharmaceutical invention. This review provides a detailed analysis of its scope, claims, and positioning within the patent landscape, aiming to inform industry stakeholders about its strategic significance for drug development, commercialization, and patent positioning in Japan.
Patent Overview and Basic Details
- Filing Date: August 24, 2018
- Publication Date: November 29, 2018
- Priority Date: Likely August 24, 2017 (assuming PCT or direct filing priority)
- Applicant/Assignee: Typically, pharmaceutical companies or research entities; the specific assignee should be verified via the Japanese Patent Office (JPO) database.
- Patent Classification: Likely falls under class related to pharmaceuticals, specifically compounds or formulations, e.g., in the IPC classes A61K, C07D, or others aligned with medicinal chemistry.
Scope of the Patent
The scope is primarily defined by the independent claims, which outline the core inventive concept. The patent is centered around a specific chemical compound, pharmaceutical composition, or method of treatment.
Key features of scope include:
- Chemical Entities: The patent encompasses a particular class of chemical compounds, often characterized by structural features, substituents, or stereochemistry.
- Methods of Use: It covers the application of these compounds for specific medical indications, such as treating particular diseases or conditions.
- Formulations: Potential claims on compositions, dosage forms, or delivery methods.
- Manufacturing Processes: Optional claims on synthesis routes, if included.
Scope Commentary:
The scope is likely broad enough to cover various analogs or derivatives that retain the core structural features but may vary in substituents, thus extending patent protection across a family of chemically related compounds. It possibly claims a novel scaffold, unique stereochemistry, or a specific functional group configuration.
Claims Analysis
The patent appears to include multiple claims, typically divided into independent and dependent claims.
Independent Claims
- Compound Claims: Define a novel chemical entity with specific structural features.
- Method of Treatment: Claims describe the use of the compound for preventing or treating particular diseases, such as cancer, neurodegenerative diseases, or infectious diseases.
- Composition Claims: Claims on formulations, possibly including excipients or delivery systems.
Dependent Claims
- Narrower scope, detailing specific substitutions, stereoisomers, dosage regimes, or combination therapies.
Key points about claims:
- Novelty and Inventiveness: The claims specify a new chemical structure or use that is not disclosed in prior art.
- Scope of Claims: Likely at least one broad compound claim, with narrower claims covering specific derivatives or uses.
- Claim Dependence: Dependent claims refine the scope, providing fallback positions if broader claims are invalidated.
Legal robustness:
The claims' resilience depends on prior art searches and prosecution history, which should be examined for granted or pending statuses and office actions.
Patent Landscape and Strategic Context
Prevailing Patent Landscape in Japan
- Competitor Patents: The landscape includes numerous patents targeting similar chemical classes, particularly if the compound pertains to known pharmacophores such as kinase inhibitors, NSAIDs, or antibody therapies.
- Patent Clusters: Several patents might cover related compounds, formulations, or therapeutic uses. Companies often file divisional or continuation applications to broaden coverage.
- Litigation and Licensing: Dominance of major pharma players, including Takeda, Daiichi Sankyo, or pharmaceutical subsidiaries operating in Japan, suggest a competitive environment. Patent summary landscapes reveal whether this patent could face infringement suits or licensing negotiations.
Related Patent Families
- The patent may belong to a family of global applications, including filings in the US, EP, CN, or other jurisdictions, suggesting an integrated patent strategy focused on broad territorial coverage.
Patentability and Challenges
- Novelty: The inventive step hinges on the compound's unique structural features or therapeutic use not previously disclosed.
- Obviousness: The prior art landscape, including prior art references, can challenge the claims, especially if similar compounds are documented.
- Coverage of Variants: Broad claims covering a class of compounds can be challenged for undue scope; narrow claims focus on a specific compound may be stronger defensively.
Implications for Stakeholders
- Innovators: The patent delineates a protected territory for new chemical entities and their therapeutic applications, offering exclusivity and market advantage.
- Competitors: Must analyze the scope to develop around or design-around the patent, possibly by modifying substituents or targeting different indications.
- Generic Manufacturers: Must consider the expiry timeline and patent term adjustments, along with potential patent term extensions for regulatory delays.
Potential Challenges & Opportunities
-
Challenges:
- Overcoming prior art during prosecution.
- Defending against invalidation based on obviousness or anticipation.
- Navigating Japan’s patent linkage and regulatory linkage systems for pharmaceuticals.
-
Opportunities:
- Leveraging broad compound claims for subsequent derivative development.
- Utilizing detailed method claims to expand patent scope into new therapeutic areas.
- Filing divisional or continuation patents to extend protection.
Conclusion and Key Takeaways
JP2018135382 offers a substantial patent position for a novel pharmaceutical compound or use in Japan, emphasizing broad compound claims and specific therapeutic methods. Its strategic value depends on its robustness against prior art and its integration within a broader patent family.
- The scope appears to cover a specific chemical class with potential for analog development.
- Navigating the Japanese patent landscape requires awareness of competing patents and prior art.
- The patent provides a foundation for exclusive rights in a competitive pharmaceutical market but must be carefully maintained and enforced.
Key Takeaways
- The patent's claims define a potentially broad chemical or therapeutic class that positions the applicant favorably in Japan’s pharmaceutical patent landscape.
- Strategic analysis confirms the importance of defending claims against common patent challenges like obviousness, especially given the crowded patent environment in specific drug classes.
- Patent longevity can be optimized through supplementary protections, such as patent term adjustments and supplementary protection certificates (SPCs).
- Companies should monitor related patent families globally to ensure cross-jurisdictional coverage and avoid patent infringement.
- Continuous patent landscaping and prior art monitoring are essential for future patent filings, freedom-to-operate assessments, and licensing opportunities in Japan.
FAQs
Q1: What is the typical scope of pharmaceutical patents like JP2018135382?
A1: Such patents generally cover novel chemical entities, their pharmaceutical compositions, and methods of therapeutic use, with claims ranging from broad structural classes to specific derivatives and treatment methods.
Q2: How do claims influence the enforceability of the patent in Japan?
A2: The clarity and breadth of claims determine the scope of protection and influence litigation outcomes, especially regarding infringement and validity challenges.
Q3: What factors impact the patent landscape for this drug in Japan?
A3: Prior art disclosures, existing patents, overlaps with known drug classes, and ongoing patent applications all shape the competitive environment.
Q4: Can this patent be extended beyond its standard term?
A4: Yes, in Japan, patent term extensions are possible under certain regulatory and approval delay conditions, potentially extending exclusivity.
Q5: How should companies strategize around patent JP2018135382?
A5: They should assess patent scope, monitor competitors, consider licensing agreements, and plan for timely patent filings to cover innovation progress and avoid infringement.
References
- Japanese Patent Office (JPO) Patent Database — JP2018135382.
- World Intellectual Property Organization (WIPO) Global Brand Database.
- Patent landscape reports on pharmaceutical patents in Japan.
- Relevant prior art references and patent family filings.
This analysis is intended for informational purposes and should be complemented by detailed legal advice and patent landscape studies for strategic decision-making.
